According to estimates of a recent market study by Persistence Market Research (PMR), the global diabetic nephropathy market is poised to exhibit a CAGR of 5.6% from 2014 to 2020. The report, titled “Global Market Study on Diabetic Nephropathy: Asia to Witness Highest Growth by 2020”, states that the market, with a valuation of US$2,262.2 million in 2014, is expected to reach US$3,145.9 million ... Read more
Growing prevalence of diabetes and obesity, increasing R&D investments in drug discovery and development, and rising awareness about diabetes and kidney-related disorders are some of the major drivers of the diabetic nephropathy market. A new research report with a title “Global Market Study on Diabetic Nephropathy: Asia to Witness Highest Growth by 2020” has been added to the vast online database of Market Research Reports Search Engine (MRRSE). The report analyzes the ... Read more
Leading players in the global diabetic nephropathy market include Mitsubishi Tanabe Pharma Corporation, Siemens AG, GE, Eli Lilly and Company, AbbVie Inc., Pfizer Inc., Reata Pharmaceuticals Inc., Novartis AG, Sanofi, Abbott, Bayer AG, and Merck & Co. Inc.
In July 2019, researchers found a connection between the presence of metabolic syndrome in diabetes sufferers and the progression of diabetic nephropathy. Research projects such as ... Read more
Diabetic Nephropathy Market Industry Research Report focuses Market Size, Share, Growth and Forecast to 2025. This marketing research Report based upon factors on which the businesses compete within the market and this factor which is beneficial and valuable to the business. This report was published stating that the worldwide Diabetic Nephropathy Market is anticipated to expand significantly at Million US$ in 2019 and is projected to succeed in ... Read more
